However, upregulating ADAM17 or using ADAM17 agonist PMA significantly increased the protein level of sLRIG3 in supernatant of glioma cell lines (Fig. 2e, f and Supplementary Fig. 1b). Here, ADAM17 is linked to central nervous system cancer.